TCM from oesophageal adenocarcinoma significantly enhanced CD54 (p < 0.001), CD80 (p < 0.001), HLA-DR (p = 0.001), CD86 (p < 0.001) and CD83 (p < 0.001) compared to LPS-induction in background media alone, cM199 (+) (Fig. 2a). Here, CD80 is linked to esophageal adenocarcinoma.